NTRB Nutriband Corp Total Business Assets

Official company branding of nutriband.com (NTRB)

Nutriband Inc. (NTRB) is developing innovative transdermal systems with overdose protection, minimizing patent threats by applying the technology across various types of analgesics. This price action reflects that total assets amount to 8.23. The business relies on the success of medical trials and remains independent of economic cycles, although market capitalization and access to investment depend on macroeconomics.

Nutriband Corp (NTRB) Aggregate Company Assets: for the period 07/04/2022 - 10/31/2026

Analytical breakdowns and data insights for company nutriband.com (NTRB)

- share price and consensus valuation forecast:
Price Chart Nutriband|NTRB - Price Target Chart
- market capitalization data:
Market Capitalization NTRB|NTRB - Enterprise Value
- book capitalization information:
Book Value per Share Nutriband|NTRB - Company Book Value|Market Value to Book Value nutriband.com|NTRB - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Nutriband Inc.|NTRB - Long-Term Debt to Equity|Current Liabilities to Capital Nutriband|NTRB - Company Total Debt|Debt to Net Assets Ratio NTRB|NTRB - Company Long-Term Debts|Current Liabilities Nutriband|Quick Ratio nutriband.com
- earnings and market multiples details:
NTRB - Company Net Income
Summary company analysis:Nutriband Corp (NTRB)
Core merchandise of Nutriband Inc.

This metric is a reverse derivative of return on assets (ROA), combining equity and liabilities to restore continuous resource dynamics between reporting periods. Analyzing the total asset level of Nutriband Inc. allows for an assessment of the scaling of its material base, where the growth in asset value directly reflects investments in the development of the proprietary Aversa technology for transdermal systems.

Direct competitors

INDV (indivior.com) - Aggregate Company Assets|Aggregate Company Assets Collegium Pharmaceutical, Inc.|Total Business Assets CRON (Cronos Group Inc)|Company Total Assets CGC|Company Total Assets Canna Cabana (HITI)|Aggregate Company Assets Aurora Cannabis Inc. ACB|Aggregate Asset Value ACHV|Skye Bioscience - Company Total Assets|Anebulo Pharmaceuticals Inc (ANEB) - Cumulative Company Assets|intercure.co (INCR) - Aggregate Company Assets|Company Assets Nasus Pharma (NSRX)|Cumulative Company Assets IGC|MIRA: Aggregate Asset Value|Company Total Assets FLGC|IMCC: Total Asset Value of Company|Company Total Assets ADIL (Adial Pharmaceuticals, Inc.)|Company Total Assets Artelo Biosciences Inc. ARTL|ENSC - Aggregate Company Assets|Aggregate Asset Value TTNP (Titan Pharmaceuticals)|Greenlane (GNLN) - Aggregate Company Assets|Cumulative Company Assets InMed Pharmaceuticals Inc|Aggregate Company Assets Akanda Corporation|Total Business Assets ENVB (Enveric Corp)|Cumulative Company Assets BGXX (Bright Green)|Company Total Assets Hempacco Co Inc. (HPCO)